Journal
BMJ Open
Publication Date
5-30-2022
Volume
12
Issue
5
First Page
e060342
Document Type
Open Access Publication
DOI
10.1136/bmjopen-2021-060342
Rights and Permissions
Kasi PM, Chakrabarti S, Sawyer S, Krainock M, Poklepovic A, Ansstas G, Maninder M, Malhotra M, Ensor J, Gao L, Eroglu Z, Ellers S, Billings P, Rodriguez A, Aleshin A. BESPOKE IO protocol: a multicentre, prospective observational study evaluating the utility of ctDNA in guiding immunotherapy in patients with advanced solid tumours. BMJ Open. 2022 May 30;12(5):e060342. doi: 10.1136/bmjopen-2021-060342. https://bmjopen.bmj.com/content/12/5/e060342 © Author(s) (or their employer(s)) 2022. Re- use permitted under CC BY- NC.
Recommended Citation
Kasi, Pashtoon Murtaza; Chakrabarti, Sakti; Sawyer, Sarah; Krainock, Michael; Poklepovic, Andrew; Ansstas, George; Maninder, Minu; Malhotra, Meenakshi; Ensor, Joe; Gao, Ling; Eroglu, Zeynep; Ellers, Sascha; Billings, Paul; Rodriguez, Angel; and Aleshin, Alexey, "BESPOKE IO protocol: A multicentre, prospective observational study evaluating the utility of ctDNA in guiding immunotherapy in patients with advanced solid tumours." BMJ Open. 12, 5. e060342 (2022).
https://digitalcommons.wustl.edu/open_access_pubs/12010
